Sign in
8-K

Current Report

Spyre Therapeutics, Inc. Filed Acc 0001564590-18-024362

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading agle-8k_20181017.htm…